Cabozantinib in Advanced Salivary Gland Cancer Patients
Clinical trial NCT03729297 · TERMINATED
Trial details
- NCT number
- NCT03729297
- Sponsor
- Radboud University Medical Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-05
- Primary completion
- 2019-11-06
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.